001     901837
005     20230918092305.0
024 7 _ |a 10.1186/s42466-021-00151-y
|2 doi
024 7 _ |a 2128/28773
|2 Handle
024 7 _ |a altmetric:114506750
|2 altmetric
024 7 _ |a pmid:34602097
|2 pmid
024 7 _ |a WOS:001045956300001
|2 WOS
037 _ _ |a FZJ-2021-03858
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Goereci, Yasemin
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a Successful treatment of thromboses of major arteries after ChAdOx1 nCov-19 vaccination
260 _ _ |a [London]
|c 2021
|b BioMed Central
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1646035080_1933
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The ChAdOx1 nCoV-19 adenoviral vector vaccine to prevent contracting Covid-19 caused by infection with SARS-CoV-2 has been associated with vaccine-induced immune thrombotic thrombocytopenia (VITT) primarily leading to venous thromboses. Here, we report two cases of major arterial occlusions after ChAdOx1 nCov-19 vaccination, comprising a 42-year-old woman with thrombotic occlusion of the left carotid artery, and a 62-year-old man with occlusion of distal aorta and iliac arteries. Both were successfully treated with intravenous immunoglobulins and non-heparin anticoagulant agents leading to a beneficial short-term outcome of 6 weeks in case 1 and four months in case 2.
536 _ _ |a 5251 - Multilevel Brain Organization and Variability (POF4-525)
|0 G:(DE-HGF)POF4-5251
|c POF4-525
|f POF IV
|x 0
536 _ _ |a 5252 - Brain Dysfunction and Plasticity (POF4-525)
|0 G:(DE-HGF)POF4-5252
|c POF4-525
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Kleineberg, Nina N.
|0 P:(DE-Juel1)171203
|b 1
700 1 _ |a Madlener, Marie
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Neuschmelting, Hannah
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Fink, Gereon R.
|0 P:(DE-Juel1)131720
|b 4
700 1 _ |a Warnke, Clemens
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Stetefeld, Henning
|0 P:(DE-HGF)0
|b 6
773 _ _ |a 10.1186/s42466-021-00151-y
|g Vol. 3, no. 1, p. 52
|0 PERI:(DE-600)2947493-0
|n 1
|p 52
|t Neurological research and practice
|v 3
|y 2021
|x 2524-3489
856 4 _ |u https://juser.fz-juelich.de/record/901837/files/Goereci_2021_Neurol%20Res%20Pract_Successful%20treatment%20of%20thromoses...letter%20to%20the%20editor.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:901837
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)171203
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)131720
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5251
|x 0
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5252
|x 1
914 1 _ |y 2021
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2020-09-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2020-09-08
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2020-09-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-09-08
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21